Condition

Triple Negative Breast Neoplasms clinical trials and research

• 14Clinical trials
• 44Countries

Newest Triple Negative Breast Neoplasms clinical trials

All recruiting trials (14)

• Breast cancer subtypes and outcomes in Colombian women

  This study looks back at medical records of women with breast cancer to see how different molecular subtypes relate to survival and recurrence in a single Colombian hospital.

  Recruiting Fundación Santa Fe de Bogota · Bogotá, Bogota D.C. · NCT07856225

• Sacituzumab tirumotecan plus pembrolizumab and chemotherapy for high-risk early triple-negative and HR-low/HER2-negative breast cancer

  This trial will test whether adding sacituzumab tirumotecan and pembrolizumab to chemotherapy helps people with high‑risk early-stage triple‑negative or HR‑low/HER2‑negative breast cancer have fewer cancer cells in their tumors and lymph nodes before surgery.

  Recruiting at 331 sites Phase 3 Merck Sharp & Dohme LLC · Gilbert, Arizona and 334 other locations · NCT06966700

• Treatment for triple-negative breast cancer using sacituzumab tirumotecan and pembrolizumab

  This study is testing if a new treatment combining sacituzumab tirumotecan and pembrolizumab can help people with triple-negative breast cancer live longer and keep their cancer from getting worse compared to regular chemotherapy.

  Recruiting at 274 sites Phase 3 Merck Sharp & Dohme LLC · Mobile, Alabama and 284 other locations · NCT06841354

• Evaluating NKT3964 for Adults with Advanced Solid Tumors

  This study is testing a new drug called NKT3964 to see if it can safely help adults with advanced solid tumors, like ovarian or triple-negative breast cancer, after other treatments have failed.

  Recruiting at 17 sites Phase 1 NiKang Therapeutics, Inc. · Little Rock, Arkansas and 20 other locations · NCT06586957

• Evaluating LY4170156 for advanced solid tumors

  This study is testing a new drug called LY4170156 to see if it is safe and effective for people with advanced solid tumors like ovarian and lung cancers.

  Recruiting at 24 sites Phase 1 Eli Lilly and Company · Scottsdale, Arizona and 24 other locations · NCT06400472

• Combination of UTD1 and capecitabine for treating triple negative breast cancer

  This study is testing if combining UTD1 with capecitabine can help people with triple negative breast cancer who didn't fully respond to earlier treatment.

  Recruiting Phase 2 Hunan Cancer Hospital · Changsha, Hunan · NCT06385990

• Testing UCB4594 for advanced cancer treatment

  This study is testing a new drug called UCB4594 to see if it can help treat advanced cancer by targeting a specific protein on cancer cells.

  Recruiting at 3 sites Phase 1/2 Cancer Research UK · London and 3 other locations · NCT06380816

• Combining bicalutamide and abemaciclib for advanced androgen receptor-positive triple-negative breast cancer

  This study is testing if combining two medications, bicalutamide and abemaciclib, can help people with advanced triple-negative breast cancer feel better after their previous treatments.

  Recruiting at 5 sites Phase 2 Universitaire Ziekenhuizen KU Leuven · Antwerp and 5 other locations · NCT06365788

• Combining pembrolizumab with cryoablation for metastatic breast cancer

  This study is testing if combining a drug called pembrolizumab with a freezing treatment can help people with advanced triple negative breast cancer feel better compared to just using the drug alone.

  Recruiting at 7 sites Phase 1 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT06246968

• Combining capecitabine with pembrolizumab for triple negative breast cancer after surgery

  This study is testing if combining the cancer drugs capecitabine and pembrolizumab can help people with triple negative breast cancer who still have some cancer left after surgery live longer without the disease coming back.

  Recruiting at 20 sites Phase 2 Unicancer · Amiens and 19 other locations · NCT05973864

• New treatment approach for BRCA1/2 mutated triple negative breast cancer

  This study is testing a new treatment combining Olaparib and Pembrolizumab for people with BRCA1/2 mutated triple negative breast cancer to see if it works better after chemotherapy.

  Recruiting at 3 sites Phase 2 Okayama University · Gifu, Gifu and 2 other locations · NCT05485766

• Testing a new drug for advanced solid tumors

  This study is testing a new drug for people with advanced solid tumors, like lung and head and neck cancers, to see if it works better when combined with another treatment after other options have failed.

  Recruiting at 62 sites Phase 1 Seagen Inc. · Birmingham, Alabama and 61 other locations · NCT05208762

• Understanding how tumor shrinkage predicts cancer response in early breast cancer patients

  This study tests if measuring how much breast tumors shrink during chemotherapy can help predict how well the treatment will work for women with early-stage breast cancer.

  Recruiting at 2 sites Phase 2 Baylor Breast Care Center · Houston, Texas and 1 other locations · NCT05020860

• Testing BMS-986340 alone and with other treatments for advanced solid tumors

  This study is testing a new treatment called BMS-986340, both on its own and with other drugs, to see how safe it is for people with advanced solid tumors.

  Recruiting at 39 sites Phase 1/2 Bristol-Myers Squibb · Clovis, California and 46 other locations · NCT04895709

Related topics

Quick answers

How many Triple Negative Breast Neoplasms clinical trials are recruiting right now?

14, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 44 countries. The most sites are in Japan (6 trials), United States (6 trials), France (5 trials), Italy (5 trials), Spain (5 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 5, Phase 1: 4, Phase 3: 2, Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →